Brief: RaQualia Pharma to fully acquire TMRC via stock swap
26/12/2016 06:33
Dec 26 (Reuters) - RaQualia Pharma Inc 4579.T :
* Says RaQualia Pharma enters into agreement to fully
acquire TMRC Co Ltd which is engaged in anticarcinogen related
business, through stock swap, with effective date on Feb. 3,
2017
* One share of TMRC's stock will be exchanged with 90 shares
of co's stock
* 479,250 shares of co's stock will be exchanged
Source text in Japanese: https://goo.gl/aXc5mK
Further company coverage: 4579.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 62674724;
Reuters Messaging: Cheng.Li@thomsonreuters.com@reuters.net))